Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lange

Showing results (381-390 of 392) with videos related to

Pageof 40
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2020
TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline <i>BRCA</i> Carriers With HER2-Negative Breast Cancer (the INFORM trial)Nadine Tung, Banu Arun, Michele R Hacker, et al.
Haematologica|January 13, 2018
Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II resultsJohn Koreth, Haesook T Kim, Paulina B Lange, et al.
Science (New York, N.Y.)|July 28, 2001
Historical overfishing and the recent collapse of coastal ecosystemsJ B Jackson, M X Kirby, W H Berger, et al.
Journal of Geriatric Oncology|September 26, 2022
'ADVANCE' (a pilot trial) ADjuVANt chemotherapy in the elderly: Developing and evaluating lower-toxicity chemotherapy options for older patients with breast cancerRachel A Freedman, Tianyu Li, Mina S Sedrak, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 13, 2017
Diagnostic accuracy of the Xpert<sup>®</sup> MTB/RIF cycle threshold level to predict smear positivity: a meta-analysisB Lange, P Khan, G Kalmambetova, et al.
Allergy|May 25, 2011
Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN studyD Hastan, W J Fokkens, C Bachert, et al.
Journal of the National Cancer Institute|April 12, 2023
Clonal hematopoiesis in older patients with breast cancer receiving chemotherapyChristina Mayerhofer, Mina S Sedrak, Judith O Hopkins, et al.
The British Journal of Dermatology|December 8, 2020
Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysisT Graier, W Salmhofer, C Jonak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 20, 2026
SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancerA C Garrido-Castro, S E Kim, T Li, et al.
Rhinology|May 15, 2017
EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitisP W Hellings, C A Akdis, C Bachert, et al.
Pageof 40

Showing results (381-390 of 392) with videos related to

Sort By:
Pageof 40
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2020
TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline <i>BRCA</i> Carriers With HER2-Negative Breast Cancer (the INFORM trial)Nadine Tung, Banu Arun, Michele R Hacker, et al.
Haematologica|January 13, 2018
Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II resultsJohn Koreth, Haesook T Kim, Paulina B Lange, et al.
Science (New York, N.Y.)|July 28, 2001
Historical overfishing and the recent collapse of coastal ecosystemsJ B Jackson, M X Kirby, W H Berger, et al.
Journal of Geriatric Oncology|September 26, 2022
'ADVANCE' (a pilot trial) ADjuVANt chemotherapy in the elderly: Developing and evaluating lower-toxicity chemotherapy options for older patients with breast cancerRachel A Freedman, Tianyu Li, Mina S Sedrak, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 13, 2017
Diagnostic accuracy of the Xpert<sup>®</sup> MTB/RIF cycle threshold level to predict smear positivity: a meta-analysisB Lange, P Khan, G Kalmambetova, et al.
Allergy|May 25, 2011
Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN studyD Hastan, W J Fokkens, C Bachert, et al.
Journal of the National Cancer Institute|April 12, 2023
Clonal hematopoiesis in older patients with breast cancer receiving chemotherapyChristina Mayerhofer, Mina S Sedrak, Judith O Hopkins, et al.
The British Journal of Dermatology|December 8, 2020
Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysisT Graier, W Salmhofer, C Jonak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 20, 2026
SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancerA C Garrido-Castro, S E Kim, T Li, et al.
Rhinology|May 15, 2017
EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitisP W Hellings, C A Akdis, C Bachert, et al.
Pageof 40